LifeStance director gets stock awards, pays taxes

LifeStance Health Group director and officer Ryan Pardo reported equity compensation vesting and related tax withholding transactions in Common Stock.

Accepted by SEC EDGAR 03/11/2026 - 07:00 PM EDT

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

LifeStance Health Group director and officer Ryan Pardo reported equity compensation vesting and related tax withholding transactions in Common Stock. On March 9, 2026, he received stock awards of 40,254 and 105,711 shares at no cost as restricted and performance-based units vested.

To cover tax obligations on these vestings, the issuer withheld 12,280, 15,841, and 38,479 shares at $6.91 per share, which the footnotes state are not open-market sales. Following these transactions, Pardo directly owned 1,102,742 shares and had indirect exposure to 2,551,520 shares held by the Kimberly Pardo Irrevocable Trust, where he disclaims beneficial ownership beyond any pecuniary interest.

Insider Trade Summary

5 transactions reported

Mixed 5 txns

Insider Pardo Ryan

Role See Remarks

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	12,280	$6.91	$85K
Grant/Award	Common Stock	40,254	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	15,841	$6.91	$109K
Grant/Award	Common Stock	105,711	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	38,479	$6.91	$266K
Holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 1,102,742 shares (Direct); Common Stock — 2,551,520 shares (Indirect, By Trust)

Footnotes (6)

F1. Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of restricted stock units ("RSUs") that vested on March 9, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale.
F2. Represents performance-based restricted stock units ("PSUs") previously granted to the Reporting Person on March 6, 2025, which vested on March 9, 2026.
F3. Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of PSUs that vested on March 9, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested PSUs and do not constitute any open-market sale.
F4. Represents PSUs previously granted to the Reporting Person on February 27, 2025, which vested on March 9, 2026.
F5. Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of PSUs that vested on March 9, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested PSUs and do not constitute any open-market sale.
F6. Shares held of record by Kimberly Pardo Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities on this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Securities and Exchange Act of 1934 or for any other purpose.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Ryan Pardo report for LifeStance Health Group (LFST)?

Ryan Pardo reported the vesting of restricted and performance-based stock units and related tax-withholding share dispositions. He received stock awards of 40,254 and 105,711 Common Stock shares and had shares withheld to satisfy tax obligations tied to these vestings.

Were any of Ryan Pardo’s LFST transactions open-market stock sales?

No, the filing states the dispositions were tax-withholding transactions, not open-market sales. Shares were withheld by the issuer at $6.91 per share to satisfy tax obligations arising from vested restricted stock units and performance-based restricted stock units.

How many LifeStance (LFST) shares does Ryan Pardo hold directly after these transactions?

After the reported awards and tax withholdings, Ryan Pardo directly owned 1,102,742 shares of LifeStance Common Stock. This figure reflects his direct position following the March 9, 2026 equity compensation vesting and associated tax-withholding entries.

What is the role of the Kimberly Pardo Irrevocable Trust in the LFST filing?

The filing shows 2,551,520 LFST shares held by the Kimberly Pardo Irrevocable Trust as indirect ownership. The footnote explains Pardo disclaims beneficial ownership of these securities except for any pecuniary interest associated with the trust’s holdings.

What do the tax-withholding transactions in LFST shares represent for Ryan Pardo?

The tax-withholding entries represent shares withheld by LifeStance to cover tax obligations on vested RSUs and PSUs. The company reduced the shares delivered to Pardo by 12,280, 15,841, and 38,479 shares, instead of him selling shares in the open market.

What kind of stock awards did Ryan Pardo receive from LifeStance (LFST)?

He received Common Stock from vesting of restricted stock units and performance-based restricted stock units. The filing notes PSUs previously granted on March 6, 2025 and February 27, 2025 vested on March 9, 2026, resulting in new share awards at no purchase price.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pardo Ryan

(Last)

(First)

(Middle)

C/O LIFESTANCE HEALTH GROUP, INC.

4800 N. SCOTTSDALE ROAD, SUITE 2500

(Street)

SCOTTSDALE

85251

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
LifeStance Health Group, Inc. [ LFST ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	See Remarks

3. Date of Earliest Transaction (Month/Day/Year)
03/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/09/2026		F⁽¹⁾		12,280	D	$6.91	1,011,097	D
Common Stock	03/09/2026		A		40,254⁽²⁾	A	$0	1,051,351	D
Common Stock	03/09/2026		F⁽³⁾		15,841	D	$6.91	1,035,510	D
Common Stock	03/09/2026		A		105,711⁽⁴⁾	A	$0	1,141,221	D
Common Stock	03/09/2026		F⁽⁵⁾		38,479	D	$6.91	1,102,742	D
Common Stock								2,551,520	I	By Trust⁽⁶⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of restricted stock units ("RSUs") that vested on March 9, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale.

2. Represents performance-based restricted stock units ("PSUs") previously granted to the Reporting Person on March 6, 2025, which vested on March 9, 2026.

3. Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of PSUs that vested on March 9, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested PSUs and do not constitute any open-market sale.

4. Represents PSUs previously granted to the Reporting Person on February 27, 2025, which vested on March 9, 2026.

5. Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of PSUs that vested on March 9, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested PSUs and do not constitute any open-market sale.

6. Shares held of record by Kimberly Pardo Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities on this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Securities and Exchange Act of 1934 or for any other purpose.

Remarks:

Chief Legal Officer and Secretary

	By: /s/ Ryan Pardo	03/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR